Overall, FGF‐23 is an earlier biomarker for phosphate derangement as compared to other routine biomarkers such as PTH and phosphate, and could identify CKD cats benefiting from dietary management in an earlier stage. This evidence concerns the gene PTH and chronic kidney disease.